The burden of CVD & T2DM in South East Asia: Call for action
Transcript of The burden of CVD & T2DM in South East Asia: Call for action
The burden of CVD & T2DM in
South East Asia: Call for action
Pham Manh Hung, MD
Hanoi, Vietnam
Diabetes & Cardiovascular Disease: What are the challenges?
Asian Cardio Diabetes ForumMarch 30-31, 2019 - Hanoi, Vietnam
2
Diabetes is the world’s
THIRD MOST
POPULOUS country1
by 2040
629 MILLIONwill have Diabetes1
425 MILLION have Diabetes
>90% of cases are T2DM1
4 MILLION Number of deaths due to Diabetes1
Number of
FDA-approved
DIABETES
DRUGS3
1. 2017 IDF Diabetes Atlas 2. 2013 National Nutrition Survey 3. Gourgari E et al. Journal of Diabetes and Its Complications 2017;31:1719-1727.
Global Snapshot: The Emergence of Diabetes Nation…
17 Medications
12 Classes
19 Combinations
WHO Region
3
South – East Asia Western Pacific
Number of people with diabetes
worldwide and per region
in 2017 and 2045 (20-79 years)
IDF Atlas 2017
5
o 1 in 11 adults have diabetes.
o ~170 million people have diabetes; will rise to 208 million by
2045.
o highest number of people with diabetes among the IDF regions.
o More than half (54%) of them have not been diagnosed and are
at a higher risk of developing harmful and costly complications.
o Home to 37% of the total number of diabetics in the world.
o Highest number of deaths due to diabetes (1.7 million) among
the IDF regions.
o Despite being the region with the highest diabetes burden, only
USD 136.1 billion will be spent on treating diabetes – 16% of
the total worldwide.
2017 IDF Diabetes Atlas
1. China
2. Indonesia
3. Japan
4. Thailand
5. Philippines
Top 5 Countries
Diabetes is Highest in the Western Pacific Region
6
“Rising Star”: Diabetes in Southeast Asia
1. India
2. Bangladesh
3. Sri Lanka
4. Nepal
5. Mauritius
Top 5 Countries
o 1 in 12 adults have diabetes.
o 84 million have diabetes (2nd highest region); will rise to 156 million by 2045.
o More than half (58%) have not been diagnosed and are at a higher risk of harmful & costly complications.
o Second highest number of deaths due to diabetes (1.3 million) among the IDF regions.
o Second lowest diabetes-related expenditure per person with diabetes (USD 9.7 billion).2017 IDF Diabetes Atlas
High propotion of undiagnosed diabetes patients in SEA and WP
IDF Atlas 2017
9
Plausible Factors for High Propensity to Develop DM Among Asians
Ramchandran A et al. Diabetes Research and Clinical Practice 2014;231-237.
11
88%
78%
35%
61%
80%
25%
89% 86%
26%
59%
84%
27%
0%
20%
40%
60%
80%
100%
YOD LOD
Data from a web-based T2DM registry that included 41,029 patients from 9 Asian countries
enrolled between November 2007 to December 2012
Prevalence of Cardio-Metabolic Risk Factors in Asian Diabetics
Yeung RO et al. Lancet Diabetes Endocrinol 2014; 2: 935-943.
At diagnosis of early onset T2D, Higher prevalence of macro-
and micro-vascular complication in South Asian patients
0
2
4
6
8
10
12
14
16
18
European South Asian
An International Journal of Medicine, Volume 95, Issue 4, 1 April 2002, Pages 241–246
132017 IDF Diabetes Atlas
Trends in Age-Standardized Rates of Diabetes-Related Complications among U.S. Adults with and without Diagnosed Diabetes, 1990-2010. Adapted from Gregg et al. N Engl J Med 2014;370:1514‒23.
Pre-statin era Pre-ACEI/ARB era
Diabetes-related CV complications have declined with improved care,
but substantial burden remains
Initial presentation of CV diseases
in type 2 diabetes patients
Lancet Diabetes Endocrinol 2015; 3: 105–13
16.2%
14.1%
16
Diabetes confers a 60–80% greater
probability of CV death and all-cause
mortality in those with established HF2,3*
People with diabetes
have a 2- to 5-fold higher
risk of developing HF1
2–5
People with Diabetes are at Increased Risk of Heart Failure
Sarwar N et al. Lancet 2010;375:2215.
17
Kaplan–Meier survival curves of HF patients hospitalised with LVEF ≥50% (n=498) and <50% (n=754)
Su
rviv
al
pro
po
rtio
n
Time (years)
p=0.0322RR=1.41
LVEF ≥50%
Diabetes No diabetes
1.0
0.8
0.6
0.4
0.2
0.00 2 4 6 8 10 12
0.4
0.2
0.00 2 4 6 8 10 12
p<0.0001
RR=1.73
LVEF <50%
Diabetes No diabetes
Time (years)
1.0
0.8
0.6
0.0
Varela-Roman A et al. Eur J Heart Failure 2005;7:859.
Diabetes Worsens Heart Failure Prognosis
Higher Diabetes Prevalence in Asian than White Patients
With Heart Failure
Bank et al J Am Coll Cardiol 2017;5:14-24
Number of death due to diabetes
IDF Atlas 2017
20
Stroke(%)
MI (%)
Angina (%)
Heart Failure (%)
Atherosclerosis(%)
CAD (%)
CVD (%)
Africa 5 NR NR NR NR 23.6 28.6
Europe 7.2 10 14.6 19 33 15.4 30
Middle East &
North Africa7.1 11.4 NR NR NR 27.4 26.9
North America &
Carribean10.9 13.6 17.2 29.5 NR 20.1 46
South &
Central America5.5 NR NR 4.2 NR 22.6 27.5
Southeast Asia 3.1 NR NR NR NR 29.4 42.5
Western Pacific 11.4 NR NR 4.3 26 23.6 33.6
Prevalence of Cardiovascular Disease in T2DM
Einarson TR et al. Cardiovasc Diabetol 2018;17:83.
21
0%
10%
20%
30%
40%
50%
60%
CV Disease Renal causes Other causes
Type 1 DM Type 2 DM
CV Disease is the Most Common Cause of Death in Diabetics
Morrish NJ1,et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001 Sep;44 Suppl 2:S14-21.
22
0
20
40
60
80
100
120
140
0 1 2 3
Ag
e-a
dju
ste
d C
VD
death
ris
k/1
0,0
00
pers
on
-years
Number of risk factors
Diabetes
No diabetes
CV Death is Increased in Patients with DM +/- Other Risk Factors
Stamler J et al. Diabetes Care 1993;16:434.
23
Data from a web-based T2DM registry that included 41,029 patients from 9 Asian countries
enrolled between November 2007 to December 2012
Attainment of Glycemic Control in Asian Diabetics
0 20 40 60 80 100
Total (6109/27153)
Thailand (68/206)
Taiwan (14/87)
Singapore (98/272)
Vietnam (110/533)
Korea (276/1457)
Philippines (847/3770)
India (1135/3700)
China (887/4495)
Hong Kong (2674/12633)
Percentage with HbA1c <7.0%
YOD LOD
Yeung RO et al. Lancet Diabetes Endocrinol 2014; 2: 935-943.
24
Data from a web-based T2DM registry that included 41,029 patients from 9 Asian countries
enrolled between November 2007 to December 2012
Attainment of Blood Pressure Control in Asian Diabetics
Yeung RO et al. Lancet Diabetes Endocrinol 2014; 2: 935-943.
0 20 40 60 80 100
Total (7327/32978)
Thailand (68/206)
Taiwan (12/92)
Singapore (98/271)
Vietnam (113/590)
Korea (270/1445)
Philippines (1345/5943)
India (1820/7138)
China (919/4636)
Hong Kong (2682/12657)
Percentage with BP <130/80 mm Hg
YOD LOD
25
Data from a web-based T2DM registry that included 41,029 patients from 9 Asian countries
enrolled between November 2007 to December 2012
Attainment of LDL-C Control in Asian Diabetics
Yeung RO et al. Lancet Diabetes Endocrinol 2014; 2: 935-943.
0 20 40 60 80 100
Total (5888/27167)
Thailand (68/205)
Taiwan (5/47)
Singapore (95/263)
Vietnam (113/585)
Korea (242/1267)
Philippines (706/3062)
India (1181/4852)
China (877/4438)
Hong Kong (2601/12457)
Percentage with LDL-C <100 mg/dL
YOD LOD
26
Data from a web-based T2DM registry that included 41,029 patients from 9 Asian countries
enrolled between November 2007 to December 2012
Attainment of BP, Glucose & LDL-C Control in Asian Diabetics
0 20 40 60 80 100
Total (5336/24341)
Thailand (68/203)
Singapore (94/259)
Vietnam (110/527)
Korea (232/1238)
Philippine (531/2385)
India (856/3009)
China (847/4270)
Hong Kong (2598/12450)
Percentage (95%CI)
YOD LOD
Yeung RO et al. Lancet Diabetes Endocrinol 2014; 2: 935-943.
VietnamTotal population (2016) 94,569,000
Gross national income per capita (PPP international $, 2013) 5,030
Life expectancy at birth m/f (years, 2016) 72/81
Probability of dying under five (per 1 000 live births, 2017) 21
Probability of dying between 15 and 60 years m/f (per 1 000 population, 2016) 182/66
Total expenditure on health per capita (Intl $, 2014) 390
Total expenditure on health as % of GDP (2014) 7.1
WHO statistics: https://www.who.int/countries/vnm/en/
Major cause of death 2016 in VN
WHO statistics: https://www.who.int/countries/vnm/en/
Time trends of Diabetes in VN
2,7
5,4
0
1
2
3
4
5
6
2002 2007
%
Series 1
Series 1
Not Aware of Diabetes: 68.9%
Data from National Survey Program of Institute of Endocrinology
Time trends of Cardiovascular DiseaseIn- hospital Data
(CAD and Rheumatic VHD at VNHI from 1990 – 2015)
4,3 5,7
11,3
18,8
27,7
37,5
60,557,8
41,2
31,5
25,121,7
0
10
20
30
40
50
60
70
1990 1995 2000 2005 2010 2015
%
Year
Grafiektitel
CAD VHD
Internal Data of VNHI
PTMC and PCI at VNHI
147327
491 560 610705
553 523 495 509 504 510396 322 348
248 255 246 211 18295 134 165
297461
719 794988 1042
1368 14061611
20502252 2310
2731
3016
4049
4712
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
PTMC PCI
Data from Cardiac Cath. Lab. Vietnam National Heart Institute
Coronary artery Profile on Angiography of DM Patient at VNHI (3000 pts. From 2005 – 2010)
• 30% PCI Patients has Diabetes
• Coro. Disease more severe:
– 3VD: 45% (vs 30% in non-diabetic)
– More diffuse disease
– Cor. Artery diameter: smaller
– LVEF: DM < non- DM’s
Data from VNHI
CONCLUSIONS
37
- The epidemic of diabetes is very alarming most especially in Western Pacific and Southeast Asia where majority of patients are located and exponential increase in new cases is expected.
- Diabetes is often associated with other cardio-metabolic risk factors that further increase the risk of developing serious and costly complications.
- Cardiovascular death is the most frequent cause of death among diabetic patients.
- A significant treatment gap exists among diabetic patients in Asia with suboptimal attainment of A1c, blood pressure, and hypertension goals that may lead to cardiovascular diseases.
- Optimization of disease management strategies and programs must be prioritized to help curb the diabetes epidemic.